1. Homepage
  2. Equities
  3. Italy
  4. Borsa Italiana
  5. Recordati
  6. Financials
    REC   IT0003828271

RECORDATI

(REC)
  Report
Delayed Borsa Italiana  -  05/23 11:35:59 am EDT
42.33 EUR   -0.54%
05/23RECORDATI : Ex-dividend day for final dividend
FA
05/18Alliance Pharma Chair to Step Down in 2023; Successor Named
MT
05/10Recordati Industria Chimica e Farmaceutica S.p.A. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: December 2019 2020 2021 2022 2023 2024
Capitalization1 7 6679 33011 6578 703--
Enterprise Value (EV)1 8 57010 19512 40510 0609 8749 766
P/E ratio 21,3x26,7x30,6x23,7x20,3x18,4x
Yield 2,66%2,32%1,95%2,62%2,92%3,15%
Capitalization / Revenue 5,17x6,44x7,38x4,95x4,57x4,29x
EV / Revenue 5,78x7,04x7,85x5,72x5,19x4,81x
EV / EBITDA 15,8x17,9x20,6x15,7x13,9x12,9x
Price to Book 6,45x7,33x8,42x5,52x4,94x4,59x
Nbr of stocks (in thousands) 204 070205 817206 325205 587--
Reference price (EUR) 37,645,356,542,342,342,3
Announcement Date 02/14/202002/22/202102/24/2022---
1 EUR in Million
Previous periodNext period
Estimates
Income Statement Evolution (Annual data)
Fiscal Period: December 2019 2020 2021 2022 2023 2024
Net sales1 1 4821 4491 5801 7581 9042 031
EBITDA1 544569602643710759
Operating profit (EBIT)1 465469490516591644
Operating Margin 31,4%32,4%31,0%29,3%31,1%31,7%
Pre-Tax Profit (EBT)1 444456463467552604
Net income1 369355386386441481
Net margin 24,9%24,5%24,4%21,9%23,2%23,7%
EPS2 1,761,701,851,782,082,30
Dividend per Share2 1,001,051,101,111,241,33
Announcement Date 02/14/202002/22/202102/24/2022---
1 EUR in Million
2 EUR
Previous periodNext period
Estimates
Income Statement Evolution (Quarterly data)
Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4
Net sales1 385424419436442472
EBITDA1 147154163174166149
Operating profit (EBIT)1 123117131113115144
Operating Margin 31,8%27,7%31,3%26,0%26,0%30,5%
Pre-Tax Profit (EBT) 115113124---
Net income 89,389,696,7---
Net margin 23,2%21,1%23,1%---
EPS2 0,430,430,460,480,450,48
Dividend per Share ------
Announcement Date 10/28/202102/24/202205/10/2022---
1 EUR in Million
2 EUR
Previous periodNext period
Estimates
Balance Sheet Analysis
Fiscal Period: December 2019 2020 2021 2022 2023 2024
Net Debt1 9038667481 3571 1711 064
Net Cash position1 ------
Leverage (Debt / EBITDA) 1,66x1,52x1,24x2,11x1,65x1,40x
Free Cash Flow1 303382470308460505
ROE (Net Profit / Equities) 34,1%28,7%32,0%27,3%28,0%27,7%
Shareholders' equity1 1 0811 2371 2081 4141 5771 739
ROA (Net Profit / Asset) --15,4%13,1%13,6%14,1%
Assets1 --2 5122 9363 2483 407
Book Value Per Share2 5,836,196,717,678,569,22
Cash Flow per Share2 1,631,962,352,232,642,74
Capex1 31,321,321,913256,859,9
Capex / Sales 2,11%1,47%1,38%7,49%2,98%2,95%
Announcement Date 02/14/202002/22/202102/24/2022---
1 EUR in Million
2 EUR
Previous periodNext period
Estimates
Key data
Capitalization (EUR) 8 702 512 694
Capitalization (USD) 9 299 543 379
Net sales (EUR) 1 580 100 000
Net sales (USD) 1 688 501 817
Number of employees 4 303
Sales / Employee (EUR) 367 209
Sales / Employee (USD) 392 401
Free-Float 46,6%
Free-Float capitalization (EUR) 4 059 471 437
Free-Float capitalization (USD) 4 337 969 050
Avg. Exchange 20 sessions (EUR) 10 852 766
Avg. Exchange 20 sessions (USD) 11 597 314
Average Daily Capital Traded 0,12%
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA